Literature DB >> 11296013

Endophthalmitis after keratoprosthesis: incidence, bacterial causes, and risk factors.

M Nouri1, H Terada, E C Alfonso, C S Foster, M L Durand, C H Dohlman.   

Abstract

OBJECTIVES: To determine the rate of endophthalmitis in a group of patients with keratoprostheses and to analyze possible risk factors.
METHODS: A total of 108 patient eyes, operated on between 1990 and 2000 with double-plated keratoprostheses, were analyzed with regard to the surface flora, the incidence and cause of bacterial endophthalmitis or sterile vitreitis, the keratoprosthesis design, prophylactic antibiotics, concomitant immunosuppression, and preoperative diagnosis.
RESULTS: Surveillance cultures were obtained from 30 uninfected eyes. The flora was similar to that reported in the normal population and did not vary significantly with time. Thirteen cases of bacterial endophthalmitis occurred 2 to 46 months postoperatively in the patient population that had been followed up for 2 months to 17 years (average, 3 years 4 months). The incidence was 39% in 13 patients with Stevens-Johnson syndrome, 19% in 27 patients with ocular cicatricial pemphigoid, and 7% in 28 patients with ocular burns. Only 1 of the other 40 cases (consisting mostly of repeated graft failures in noncicatrizing conditions) developed endophthalmitis; this patient had a filtering bleb. All endophthalmitis pathogens were gram positive: Streptococcus pneumoniae, 23%; other streptococci, 39%; Staphylococcus aureus, 23%; and Staphylococcus epidermidis, 15%.
CONCLUSIONS: The most important risk factor for endophthalmitis after these keratoprostheses was found to be preoperative diagnosis. The rate of infection was very high in Stevens-Johnson syndrome and ocular cicatricial pemphigoid, moderate in chemical burns, and low in noncicatrizing corneal disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11296013     DOI: 10.1001/archopht.119.4.484

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  39 in total

1.  Boston type 1 keratoprosthesis: the New York Eye and Ear experience.

Authors:  A P Patel; E I Wu; D C Ritterband; J A Seedor
Journal:  Eye (Lond)       Date:  2011-12-16       Impact factor: 3.775

Review 2.  Development of hydrogel-based keratoprostheses: a materials perspective.

Authors:  David Myung; Pierre-Emile Duhamel; Jennifer R Cochran; Jaan Noolandi; Christopher N Ta; Curtis W Frank
Journal:  Biotechnol Prog       Date:  2008-04-19

3.  Effectiveness of antimicrobial peptide immobilization for preventing perioperative cornea implant-associated bacterial infection.

Authors:  Xiao Wei Tan; Tze Wei Goh; P Saraswathi; Chan Lwin Nyein; Melina Setiawan; Andri Riau; R Lakshminarayanan; Shouping Liu; Donald Tan; Roger W Beuerman; Jodhbir S Mehta
Journal:  Antimicrob Agents Chemother       Date:  2014-06-23       Impact factor: 5.191

Review 4.  Fungal Infections After Boston Type 1 Keratoprosthesis Implantation: Literature Review and In Vitro Antifungal Activity of Hypochlorous Acid.

Authors:  Silvia Odorcic; Wolfgang Haas; Michael S Gilmore; Claes H Dohlman
Journal:  Cornea       Date:  2015-12       Impact factor: 2.651

5.  The Streptococcus pneumoniae capsule is required for full virulence in pneumococcal endophthalmitis.

Authors:  Melissa E Sanders; Erin W Norcross; Zachary M Robertson; Quincy C Moore; Jonathan Fratkin; Mary E Marquart
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-22       Impact factor: 4.799

6.  Active Immunization with Pneumolysin versus 23-Valent Polysaccharide Vaccine for Streptococcus pneumoniae Keratitis.

Authors:  Erin W Norcross; Melissa E Sanders; Quincy C Moore; Sidney D Taylor; Nathan A Tullos; Rhonda R Caston; Sherrina N Dixon; Moon H Nahm; Robert L Burton; Hilary Thompson; Larry S McDaniel; Mary E Marquart
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-29       Impact factor: 4.799

Review 7.  The role of keratoprostheses.

Authors:  A Shalaby Bardan; N Al Raqqad; M Zarei-Ghanavati; C Liu
Journal:  Eye (Lond)       Date:  2017-12-01       Impact factor: 3.775

8.  Artificial corneas versus donor corneas for repeat corneal transplants.

Authors:  Masako Chen; Sueko M Ng; Esen K Akpek; Sumayya Ahmad
Journal:  Cochrane Database Syst Rev       Date:  2020-05-13

9.  Presumed endophthalmitis following Boston keratoprosthesis treated with 25 gauge vitrectomy: a report of three cases.

Authors:  Ilias Georgalas; Anastasios J Kanelopoulos; Petros Petrou; Ioannis Ladas; Eustratios Gotzaridis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-12-12       Impact factor: 3.117

10.  Current Concepts in the Management of Unique Post-keratoplasty Infections.

Authors:  Julie M Schallhorn; Jennifer Rose-Nussbaumer
Journal:  Curr Ophthalmol Rep       Date:  2015-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.